基本信息
浏览量:64
职业迁徙
个人简介
Professor Peng Hongling, 45, the current director of Hematology Department, chief physician and doctoral supervisor, has worked in the field of Hematology, especially in the field of targeted therapy and molecular mechanism of lymphocytic leukemia for nearly 20 years. He studied at the Dana Farber Cancer Institute of Harvard Medical School and studied with Professor A Thomas look, also known as "the father of zebrafish". After returning to China, the first zebrafish platform of Central South University was established. Based on this platform, the construction of the lymphocytic leukemia transgenic model and drug intervention research was completed, and the gene function of the zebrafish model was studied in combination with CRISPR / cas9 gene-editing technology. He has worked and studied in the National Natural Science Foundation of China, presided over three National Natural Science Foundation and three provincial and ministerial scientific research projects, and published more than 20 SCI papers in total. The first author published his works in the Journal of the American Society of Hematology "J throm hemat" and published his papers in the journal "leukemia" and "Lancet" as the main author, He published his works as a corresponding author in the famous journal "cancer communication" in the field of cancer research. He served as the leader of Hunan chronic lymphoblastic leukemia (CLL) cooperation group, the first provincial CLL group in China, and led the development of CLL in Hunan Province; He actively promoted and established the hematology branch of Hunan Geriatrics Association and served as the executive vice-chairman and secretary-general. As the first adult, he won the second prize of new medical technology of Central South University in 2016 and the first prize of new medical technology of Xiangya Second Hospital. He promoted the development of clinical and scientific research. He is an influential middle-aged and young expert in hematology in China.
研究兴趣
论文共 133 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
HELIYONno. 17 (2024)
Cancer Cell Internationalno. 1 (2024): 1-13
FRONTIERS IN IMMUNOLOGY (2024): 1354604-1354604
Wancheng Guo,Christopher Strouse,David Mery,Eric R. Siegel, Manit N. Munshi,Timothy Cody Ashby,Yan Cheng,Fumou Sun,Visanu Wanchai,Zijun Zhang,Clyde Bailey,Daisy V. Alapat,Hongling Peng,Samer Al Hadidi,Sharmilan Thanendrarajan,Carolina Schinke,Maurizio Zangari,Frits van Rhee,Guido Tricot,John D. Shaughnessy Jr,Fenghuang Zhan
Cancersno. 6 (2024): 1116-1116
Life sciences (2024): 122372-122372
Shiying Lei, Jiajun Sun,Yifang Xie,Xiaojuan Xiao, Xiaofeng He, Sheng Lin,Huifang Zhang,Zineng Huang,Haiqin Wang, Xusheng Wu,Hongling Peng,Jing Liu
Carcinogenesisno. 8 (2024): 527-542
SCIENTIFIC REPORTSno. 1 (2024)
Yanpeng Wang,Yuanliang Peng,Chaoying Yang,Dehui Xiong, Zeyuan Wang,Hongling Peng, Xusheng Wu,Xiaojuan Xiao,Jing Liu
Cell death & diseaseno. 9 (2024): 672-672
加载更多
作者统计
#Papers: 134
#Citation: 1396
H-Index: 21
G-Index: 34
Sociability: 6
Diversity: 4
Activity: 124
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn